Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cisplatin + interferon alpha-2b
- Development stage
- Unknown
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Intravenous, Subcutaneous
01
Overview
A combination therapy consisting of cisplatin, a platinum-based chemotherapeutic agent, and interferon alpha-2b, a recombinant human interferon. Cisplatin works by crosslinking DNA, interfering with cell division and triggering apoptosis in cancer cells. Interferon alpha-2b has immunomodulatory, antiviral, and antiproliferative effects, binding to cell surface receptors and activating signaling pathways that inhibit cell proliferation. This combination has been studied in various cancers including hepatocellular carcinoma, biliary tract cancer, and mucosal melanoma.
- Other names
- PIAF regimen (when combined with doxorubicin and 5-fluorouracil)
02
Targets
DNAIFNAR2 (Interferon alpha/beta receptor subunit 2)IFNAR (Immune system modulation via type I interferon receptor)
Beyond the preview
Go deeper on cisplatin + interferon alpha-2b.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cisplatin + interferon alpha-2b.